Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent Chemoradiotherapy with Docetaxel and Carboplatin for NSCLC
NCT00664105Phase 2Terminated
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Feb 2004
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by Vanderbilt-Ingram Cancer Center. Started Feb 2004; status: terminated.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00664105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00664105.